shikonin

a naphthazarin; has antineoplastic and angiogenesis inhibiting activities

Also Known As:

(+)-shikonin; (+-)-shikonin; (R)-(+)-shikonin; 1,4-naphthalenedione, 5,8- dihydroxy- 2- ((1R)- 1- hydroxy- 4- methyl- 3- penten- 1- yl)- ; 1,4-naphthalenedione, 5,8- dihydroxy- 2- ((1r)- 1- hydroxy- 4- methyl- 3- pentenyl)- ; 1,4-naphthalenedione, 5,8- dihydroxy- 2- (1- hydroxy- 4- methyl- 3- pentenyl)- , (R)-; 1,4-naphthoquinone, 5,8- dihydroxy- 2- (1- hydroxy- 4- methyl- 3- pentenyl)- , (+)-; 2- ((1R)- 1- hydroxy- 4- methyl- 3- pentenyl)- 5,8- dihydroxy- 1,4- naphthoquinone; 5,8- dihydroxy- 2- ((1R)- 1- hydroxy- 4- methyl- 3- penten- 1- yl)- 1,4- naphthalenedione; 5,8- dihydroxy- 2- (1- hydroxy- 4- methyl- 3- pentenyl)- 1,4- naphthalenedione; isoarnebin 4; shikonin, (+)-isomer

Pharmalogical Action Categories:

D000894 - Anti-Inflammatory Agents, Non-Steroidal

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Polycyclic Aromatic Hydrocarbons: 2020
        Naphthalenes: 18
        Naphthoquinones: 418
        shikonin: 542
- Quinones: 434
  - Naphthoquinones: 418
    - shikonin: 542
Polycyclic Compounds: 6
- Polycyclic Aromatic Hydrocarbons: 2020
  - Naphthalenes: 18
    - Naphthoquinones: 418
      - shikonin: 542

Setsuo Saito Selected Research

Setsuo Saito Research Topics

Disease

Drug/Important Bio-Agent (IBA)